2 min read

The Value of Patient Support Programs During COVID-19

UBC’s experts talk with PharmExec.com on the impact of a hub.
UBC and other industry experts spoke with PharmExcec.com about the impact a patient support program can have on patients and prescribers during a pandemic.

Nicole Hebbert (SVP, Head of Patient Support Services, UBC), Jennifer Lim (Director of Patient Services, UBC), UBC partner SK Life Science and various industry experts spoke with PharmExcec.com about the impact a patient support program or ‘Hub’ can have on patients and prescribers during a pandemic.

Assets in Anxious Times: Patient Hubs Demonstrate Value During COVID-19 article explores in detail how a hub can ease patient access, drive patient engagement, and more effectively enable speed and efficiency to therapy through technology – even throughout a global pandemic.

In-person visits have drastically prohibited patients from visiting the site of care, whether from shelter-at-home mandates, office closures, or potential fear from patients exposing themselves to the virus, hub services can ease patient’s treatment anxiety and provide supplemental options to navigate their access.

During the COVID-19 pandemic, UBC has quickly and efficiently transitioned to a dynamic remote model without client interruptions. The team has supported three different launches since March across a broad range of indications from diabetes to epilepsy. Our in-home and telephonic nurse network has provided both clients and patients the peace of mind that care will not be interrupted, and the needs of patients will continue to be prioritized.

UBC’s patient support services can be customized to meet unique program and product objectives while addressing the needs and requirements of patients, caregivers, prescribers, pharmacists, payers, and regulators. UBC applies a holistic approach to the patient care continuum designed to maximize a product’s market penetration as well as its growth potential.

To get in touch with UBC to learn how we can provide patient support programs during COVID-19 and beyond, head here.

Other Recent Posts

Press
5 min read

UBC Successfully Implemented REMS Administration Software DuringHL7® FHIR® Connectathon

UBC demonstrated our commitment to optimizing safe medication use and health outcomes by participating in the HL7® FHIR® Connectathon.
Press
5 min read

UBC Selects Oracle Cloud Safety Technology for its Safety Programs

UBC selected Oracle Life Sciences' safety case management solution.
Press
2 min read

UBC Receives CRO Leadership Award Again

UBC was honored as a winner in the 2023 CRO Leadership Awards by both big and small pharma in the Reliability category.

Thank You for Connecting with UBC

Lorem ipsum dolor sit amet consectetur. Mi proin enim ipsum nascetur. Venenatis odio scelerisque non netus ac et pellentesque.

What You Can Expect Next

Lorem ipsum dolor sit amet consectetur. Cras aliquam erat eget magna sollicitudin.

Get Ready to Change Your Business

Lorem ipsum dolor sit amet consectetur. Mi proin enim ipsum nascetur. Venenatis odio scelerisque non netus ac et pellentesque.

Service Request

Bekki Bracken Brown

President & Chief Executive Officer

Bekki Bracken Brown serves as the President and CEO of UBC, guiding the company’s mission and values, including the improvement of access for patients to receive better outcomes. She oversees all aspects of UBC, such as operations, business growth strategy, sales and marketing, and acquisition support.

With over 20 years of industry experience, Ms. Brown brings knowledge from a successful career in senior management from her tenure at Quintiles, INC Research, and, most recently, with Syneos Health. She’s been a member of the North Carolina BIO Board of Directors since 2019. She is also a member of the Healthcare Businesswomen’s Association — Southeast Chapter and CHIEF, an organization that supports women executive leaders. Ms. Brown earned her bachelor’s degree at Duke University.